Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.790
+0.020 (0.72%)
At close: Apr 17, 2026, 4:00 PM EDT
2.840
+0.050 (1.79%)
After-hours: Apr 17, 2026, 4:22 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $123.8 million as of April 17, 2026. Its market cap has increased by 30.69% in one year.
Market Cap
123.80M
Enterprise Value
110.89M
1-Year Change
30.69%
Ranking
Category
Stock Price
$2.79
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $123.80M, a decrease of -12.63%. That is a compound annual growth rate of -4.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 123.80M | -24.52% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 134.02M |
| Immunic | 130.46M |
| Oncolytics Biotech | 130.06M |
| AN2 Therapeutics | 129.91M |
| Equillium | 129.61M |
| Kazia Therapeutics | 126.84M |
| Cardiff Oncology | 123.06M |
| Cibus | 121.11M |